Cite
HARVARD Citation
Di Rocco, A. et al. (2021). Relapsed/refractory diffuse large B-cell lymphoma patients. A multicenter retrospective analysis of eligibility criteria for car-T cell therapy. Leukemia & lymphoma. 62 (4), pp. 828-836. [Online].